Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Reliv International, a nutrition and direct selling company, has introduced a blood-sugar management product GlucAffect, in Singapore, Malaysia and the Philippines.
Subscribe to our email newsletter
Reliv said that a clinical study conducted at Gabriele D’Annunzio University in Chieti-Pescara, Italy and published in the journal Phytotherapy Research found that GlucAffect reduces blood glucose levels and helped control weight in study participants.
Reportedly, the clinical study included 50 overweight individuals who had pre-diabetic glucose levels prior to the study. Subjects taking GlucAffect lowered their fasting blood glucose by an average of 30% and they lost an average of 16 pounds.
In the trial, the subjects in the control group reported a marginal decline in blood glucose levels and no significant weight loss. The participants consumed GlucAffect or a placebo four times a day for six days a week, participated in an exercise program and ate a healthy diet.
Carl Hastings, vice chairman and chief scientific officer of Reliv, said: “We believe the study results of GlucAffect represent a significant development because nutritional science increasingly is seen as a complement to traditional care and prescriptive remedies for metabolic syndrome.
“Ingredients were carefully selected based upon research, extensive testing, processes and controls instituted by Reliv’s team of nutritional scientists.”